Bright Lights conference to feature investors and disruptive demos

Managing IP is part of Legal Benchmarking Limited, 1-2 Paris Gardens, London, SE1 8ND

Copyright © Legal Benchmarking Limited and its affiliated companies 2026

Accessibility | Terms of Use | Privacy Policy | Modern Slavery Statement

Cookies Settings

Bright Lights conference to feature investors and disruptive demos

On Monday and Tuesday September 10 and 11 Managing IP will be partnering with MDB Capital Group for the third annual Bright Lights conference in New York City - an invitation-only event highlighting disruptive technologies to Wall Street investors

MDB Capital Group is Wall Street’s only IP investment bank. Its focus is exclusively on financing companies that have “disruptive, market-changing technology and intellectual property”. Its professionals have raised over $4 billion to finance over 200 companies.

The conference will feature about 30 IP companies in high-growth industries such as energy, healthcare and technology. It will include presentations from leaders in the industry, who will discuss the value of intellectual property and how to commercialise innovation. 

mdb20logo.gif

The event will include a demo room which will display some of the disruptive technologies in action. Participants will be able to literally play video games with their brain using BCInet’s patented brain-computer interface; experience the HyperSound system, which electronically converts audible tones into ultrasonic waves; and learn how Tigerlogic’s social media platform, Postano, can monetise social media. There will also be discussions with the CEO of MDB Capital Group, Chris Marlett, who will provide insight into recent patent battles and how technology companies can safeguard their IP.

Attendees of the event will be asked to fill out a questionnaire developed by Managing IP, which will be used to provide analysis following the conference. The survey includes questions such as: What factors are most important when making the decision to invest in a particular technology?; Which industries are most intriguing to investors?; and What role do high-profile patent cases play in informing risk analysis? It also asks investors about the importance of patent protection, what makes a good patent and the factors involved in their patent review processes. Answers to all questions are confidential.

The conference will be held at the New York Palace Hotel, starting with breakfast speakers at 7:30 am both days. For more information, please visit the conference website.







more from across site and SHARED ros bottom lb

More from across our site

Daniel Law CEO Alicia Daniel-Shores may have stepped into a family business, but she has spent two decades building her own vision around technology and litigation
Law firms don't particularly like saying no to clients. Perhaps they should get better at it
The office, which has a relatively new patent litigation team as well as a wider ‘soft’ IP offering, would remain independent if the rejection is rubberstamped
The IP boutique is betting that growing investment in quantum and semiconductors will fuel demand as technology shifts toward physical systems
Lawyers say the overhaul better reflects commercial reality, with changes spanning novelty searches, digital designs and access to a small claims track, but stopping short of criminalising unregistered design infringement
Carpmaels & Ransford hires its fourth partner of the year and wins access to UPC files, as fresh orders address costs, confidentiality and the use of divisional patents
Peter Ling of Lenz & Staehelin in Zurich discusses trends in patent litigation, the regulation of AI and the benefits of teaching IP
Brandsmiths and Powell Gilbert will contest claims over several UK trademarks in a High Court case examining the ownership and revival of a heritage brand
Hogan Lovells Cadwalader is taking a fresh strategic approach to pricing in its AI strategy. It could amplify calls for law firms to ditch the billable hour
Charles Harding plans to build a new team around life sciences oppositions and contentious work, drawing on his three decades developing a practice from scratch at D Young & Co
Gift this article